The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19.

In spite of the relatively high morbidity and mortality, there is no approved medication yet for COVID-19. There are more than 200 ongoing trials on different drugs or vaccines, but new medications may take until 2021 to develop. Defining the optimal number of patients to be included in a study is a considerable challenge in these interventional researches.

Risk factors for stunting among under-fives in Libya.

Objective: Stunting is a chronic condition reflecting poor nutrition and health. Our aim was to ascertain major predictors of stunting in children <5 years old in Libya.

Population And Methods: A nationally representative, cross-sectional, two-stage stratified cluster sample survey enrolled 4549 under-fives from 6707 households.

Nutritional status of under-five children in libya; a national population-based survey.

Aim: To describe the nutritional status of children under-five years of age in Libya.

Population And Methods: A secondary analysis of data of 5348 children taken from a national representative, two-stage, cluster-sample survey that was performed in 1995.

Results: Prevalence rates of underweight, wasting, stunting, and overweight were determined using standard definitions in reference to newly established WHO growth charts.